A/Prof Jonathan Payne
A/Prof Jonathan Payne
Details
Role
Co-Grp Leader/Snr Princ Research Fellow
Research area
Clinical Sciences
Group
Brain and Mind
Contact
Email
show email address
Associate Professor Jonathan Payne is co-lead of the Brain & Mind Research Group at the Murdoch Children's Research Institute, where he leads the Genetics and Neurodevelopment Team and sits on the steering committee of the Neurodevelopment Flagship. He is a practicing senior clinical neuropsychologist at the Royal Children's Hospital and an Honorary Principal Research Fellow in the Department of Paediatrics, University of Melbourne.
Associate Professor Payne's research draws on a range of cognitive, behavioural, neuroimaging, and laboratory protocols to understand how genetic variants can affect brain development and increase the risk for neurodevelopmental disorders. He is also an experienced trialist and leads several pharmacological and non-pharmacological clinical trials.
Associate Professor Payne's research draws on a range of cognitive, behavioural, neuroimaging, and laboratory protocols to understand how genetic variants can affect brain development and increase the risk for neurodevelopmental disorders. He is also an experienced trialist and leads several pharmacological and non-pharmacological clinical trials.
Associate Professor Jonathan Payne is co-lead of the Brain & Mind Research Group at the Murdoch Children's Research Institute, where he leads the Genetics and Neurodevelopment Team and sits on the steering committee of the Neurodevelopment Flagship....
Associate Professor Jonathan Payne is co-lead of the Brain & Mind Research Group at the Murdoch Children's Research Institute, where he leads the Genetics and Neurodevelopment Team and sits on the steering committee of the Neurodevelopment Flagship. He is a practicing senior clinical neuropsychologist at the Royal Children's Hospital and an Honorary Principal Research Fellow in the Department of Paediatrics, University of Melbourne.
Associate Professor Payne's research draws on a range of cognitive, behavioural, neuroimaging, and laboratory protocols to understand how genetic variants can affect brain development and increase the risk for neurodevelopmental disorders. He is also an experienced trialist and leads several pharmacological and non-pharmacological clinical trials.
Associate Professor Payne's research draws on a range of cognitive, behavioural, neuroimaging, and laboratory protocols to understand how genetic variants can affect brain development and increase the risk for neurodevelopmental disorders. He is also an experienced trialist and leads several pharmacological and non-pharmacological clinical trials.
Top Publications
- Haebich, KM, Hocking, DR, Darke, H, Mackenzie, R, North, KN, Vivanti, G, Payne, JM. Socially oriented attention in young children with neurofibromatosis type 1: An eye-tracking study.. Dev Med Child Neurol 68(4) : 541 -548 2026 view publication
- Pride, NA, Payne, JM, Haebich, K, Arnold, SS, Bournazos, A, Habib, J, Yates, C, Guzzetti, JR, Darke, H, Pascouau, R, et al. Sleep-Wake Dysregulation and Altered Melatonin in Neurofibromatosis Type 1.. Sleep 2026 view publication
- Liu, D, Wolters, PL, Klein-Tasman, BP, Walsh, KS, Payne, JM, Pride, N, Morris, SM, Hou, Y. Age-Specific ADHD and Internalizing/Externalizing Comorbidity in Children with Neurofibromatosis Type 1: A Multi-Site Study.. Cancers (Basel) 18(3) : 2026 view publication
- Bozaoglu, K, Massie, S, Irion, FE, Davies, KC, Kantor, I, Raabus, M, Haebich, KM, Vlahos, K, Howden, SE, Wright, J, et al. Simultaneous reprogramming and gene correction to generate six iPSC lines and isogenic controls from individuals with neurofibromatosis type 1.. Stem Cell Res 90: 103904 2026 view publication
- Mandal, AS, Shinohara, RT, Jung, B, Gardner, M, Akouri, HE, Yerys, BE, Low, KJ, Cole, TJ, Guthrie, W, Janke, KM, et al. NF1-Specific Growth Charts for Head Circumference Over the First 3 Years of Life.. Neurology 106(2) : e214480 2026 view publication
Page 1 of 19
Career information
Share //
